Chip simplifies COVID-19 testing, delivers results on a phone

COVID-19 can be diagnosed in 55 minutes or less with the help of programmed magnetic nanobeads and a diagnostic tool that plugs into an off-the-shelf cell phone, according to Rice University engineers. The Rice lab of mechanical engineer Peter Lillehoj has developed a stamp-sized microfluidic chip that measures the concentration of SARS-CoV-2 nucleocapsid (N) protein in blood serum from a […]

Read more

Ideal surgical results less likely if cancer patients live in vulnerable communities

A new study finds that older cancer patients are less likely to have optimal results following their cancer operation if they live in an area highly affected by social challenges, especially if they are racial-ethnic minorities. The study was selected for the 2020 Southern Surgical Association Program and published as an article in press on the Journal of the American […]

Read more

Merck Announces Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck’s Investigational 15-valent Pneumococcal Conjugate Vaccine

KENILWORTH, N.J.–(BUSINESS WIRE) October 20, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced findings from two additional Phase 3 studies evaluating the safety, tolerability and immunogenicity of V114, the company’s investigational 15-valent pneumococcal conjugate vaccine. In the PNEU-PATH (V114-016) study, healthy adults 50 years of age or older received V114 or PCV13 […]

Read more

Promising pre-clinical results for COVID-19 vaccine

A COVID-19 vaccine candidate developed by the University of Saskatchewan’s (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has cleared another major milestone in moving towards human clinical trials: the novel vaccine has proven highly effective in ferrets, one of the commonly used animal models for COVID-19. To evaluate the effectiveness of the vaccine, the ferrets received two immunizations […]

Read more

Three teams fail to replicate results of 2016 HIV study that claimed ‘cure’ in monkeys

Three separate and independent teams of researchers have attempted to replicate the results of a team which, back in 2016, claimed to have cured monkeys of an HIV-like infection. All three have published their work and findings in the journal Science. Notably, the original paper was published in the same journal. After questions arose regarding the work done by the […]

Read more

Important results for brain machine interfaces

Data from Mental Work project, conducted as an experimental artwork at EPFL’s Artlab, indicates that BMI is robust and accessible to the general public, spurring new research collaborations in Switzerland on user experience. Brain-machine interfaces are rarely found outside of medical clinics, where the disabled receive hours or days of training in order to operate wheelchairs with their minds. Now […]

Read more

First time human-on-a-chip predicts in vivo results based on in vitro model

Hesperos Inc., pioneers of the “human-on-a-chip” in vitro system has announced the use of its innovative multi-organ model to successfully measure the concentration and metabolism of two known cardiotoxic small molecules over time, to accurately describe the drug behavior and toxic effects in vivo. The findings further support the potential of body-on-a-chip systems to transform the drug discovery process. In […]

Read more

Complete Results from First Study in Ongoing Phase 3 Program for Tanezumab Demonstrated Significant Improvement in Pain and Function in Osteoarthritis Patients

NEW YORK & INDIANAPOLIS–(BUSINESS WIRE October 23, 2018 )–Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced complete results from a Phase 3 study evaluating the efficacy and safety of subcutaneous administration of tanezumab, an investigational humanized monoclonal antibody, in patients with osteoarthritis (OA) pain treated for 16 weeks. The study met all three co-primary efficacy endpoints, demonstrating […]

Read more
1 2